Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

News Conference News CRT 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

L.A. McKeown

March 10, 2025

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

Presentation TCT 2023

TCT 604: A Novel Computational Method to Predict Post-TAVR Leaflet Thrombosis from Pre-TAVR CT

Presenter: Aniket Venkatesh

October 25, 2023

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

News Conference News EuroPCR 2023

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Michael O'Riordan

May 16, 2023

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Shelley Wood

May 18, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

Advertisement

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

TCT 604: A Novel Computational Method to Predict Post-TAVR Leaflet Thrombosis from Pre-TAVR CT

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

TCT 2019 Day Two: Transcatheter Valves, New and Old

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content